524218 Stock Overview
Engages in the manufacture and marketing of specialty chemicals in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Resonance Specialties Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹102.20 |
| 52 Week High | ₹133.45 |
| 52 Week Low | ₹87.05 |
| Beta | 0.92 |
| 11 Month Change | -7.18% |
| 3 Month Change | -3.58% |
| 1 Year Change | 13.20% |
| 33 Year Change | -44.38% |
| 5 Year Change | 179.62% |
| Change since IPO | 6,713.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524218 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -0.9% | -1.9% | -1.2% |
| 1Y | 13.2% | 9.6% | 25.5% |
Return vs Industry: 524218 exceeded the Indian Chemicals industry which returned 9.6% over the past year.
Return vs Market: 524218 underperformed the Indian Market which returned 25.5% over the past year.
Price Volatility
| 524218 volatility | |
|---|---|
| 524218 Average Weekly Movement | 5.3% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524218 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524218's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 68 | Charchit Jain | www.resonancesl.com |
Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate, chromium polynicotinate, niacin, niacinamide, and Isoniazid; alpha picolinic and dipicolinic acids; solvents, including acetonitrile and valeronitrile; lutidines for anti-ulcer drugs; and collidines for omeprazole, lansoprazole, rebaprazole, and esomeprazole.
Resonance Specialties Limited Fundamentals Summary
| 524218 fundamental statistics | |
|---|---|
| Market cap | ₹1.19b |
| Earnings (TTM) | ₹40.24m |
| Revenue (TTM) | ₹670.65m |
29.3x
P/E Ratio1.8x
P/S RatioIs 524218 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524218 income statement (TTM) | |
|---|---|
| Revenue | ₹670.65m |
| Cost of Revenue | ₹443.29m |
| Gross Profit | ₹227.35m |
| Other Expenses | ₹187.11m |
| Earnings | ₹40.24m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.49 |
| Gross Margin | 33.90% |
| Net Profit Margin | 6.00% |
| Debt/Equity Ratio | 6.0% |
How did 524218 perform over the long term?
See historical performance and comparison